Position in NVS
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$424,241
+$10,747 QoQ
Shares Held
2,707
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#962
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Roundview Capital LLC holds $44,317,424 across 9 Drug Manufacturers - General names. NVS ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
72,050 | $18,298,538 | |
| 2 | LLY |
ELI LILLY & Co
|
8,070 | $9,679,400 | |
| 3 | ABBV |
AbbVie Inc.
|
30,467 | $7,666,715 | |
| 4 | MRK |
Merck & Co., Inc.
|
42,411 | $5,449,813 | |
| 5 | NVO |
Novo Nordisk A S
|
32,028 | $1,535,422 | |
| 6 | PFE |
Pfizer Inc
|
23,438 | $564,387 | |
| 7 | NVS |
Novartis AG
This page
|
2,707 | $424,241 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,618 | $381,329 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $424,241 | 2,707 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $413,494 | 2,707 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $373,765 | 2,711 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $339,194 | 2,645 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $320,071 | 2,645 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $296,313 | 2,658 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $273,149 | 2,807 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $305,723 | 2,658 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $282,970 | 2,658 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $260,590 | 2,694 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $295,236 | 2,924 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $301,403 | 2,959 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $298,592 | 2,959 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $272,228 | 2,959 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $797,065 | 8,786 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $667,823 | 8,786 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $740,651 | 8,762 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $768,865 | 8,762 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $773,147 | 8,839 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $796,210 | 9,736 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $901,359 | 9,879 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $844,456 | 9,879 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $918,520 | 9,727 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $842,381 | 9,687 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $846,761 | 9,695 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $816,007 | 9,897 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||